• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超级增强子在葡萄膜黑色素瘤中协调转录失调和代谢重编程。

Super-enhancers orchestrate transcriptional dysregulation and metabolic reprogramming in uveal melanoma.

作者信息

Pan Hui, Shao Weihuan, Wang Huixue, Ge Shengfang, Zhang Lingyu, Xu Xiaofang, Wang Yefei, Zhuang Ai

机构信息

State Key Laboratory of Eye Health, Department of Ophthalmology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Shanghai Key Laboratory of Orbital Diseases and Ocular Oncology, Shanghai, China.

出版信息

Commun Biol. 2025 Jun 23;8(1):951. doi: 10.1038/s42003-025-08338-8.

DOI:10.1038/s42003-025-08338-8
PMID:40550933
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12185695/
Abstract

Uveal melanoma (UM) is the most common intraocular malignancy in adults and frequently metastasizes. Somatic mutations and chromatin aberrations have been implicated in the pathogenesis of this deadly disease. Despite rapid progress in elucidating the genetic landscape of UM, the epigenetic architecture underlying UM pathogenesis remains incompletely understood. Here, we describe a super-enhancer-mediated epigenetic pipeline through genome-scale histone acetylation and transcriptional profiling. We first characterized the active landscape of super-enhancer profiles in UM via chromatin immunoprecipitation sequencing (ChIP-seq). We identified master transcription factors specifically driven by UM-specific super-enhancers, and our pipeline identified transcription factor AP-2 alpha (TFAP2A), which is highly associated with metabolism and oncogenesis, as the top essential regulator in UM. TFAP2A occupied predicted super-enhancers associated with the oncogene Solute Carrier Family 7 member 8 (SLC7A8) in UM, thereby elucidating a mechanism for regulating oncogene expression. Collectively, our data illustrate the potential for epigenetic targeting of super-enhancer-mediated oncogene dependencies in UM, highlighting an epigenetic vulnerability that can be exploited for precision therapy.

摘要

葡萄膜黑色素瘤(UM)是成人中最常见的眼内恶性肿瘤,且经常发生转移。体细胞突变和染色质畸变与这种致命疾病的发病机制有关。尽管在阐明UM的遗传格局方面取得了快速进展,但UM发病机制背后的表观遗传结构仍未完全了解。在这里,我们通过全基因组规模的组蛋白乙酰化和转录谱分析描述了一种超级增强子介导的表观遗传途径。我们首先通过染色质免疫沉淀测序(ChIP-seq)对UM中超级增强子图谱的活性格局进行了表征。我们鉴定了由UM特异性超级增强子特异性驱动的主转录因子,并且我们的途径鉴定出与代谢和肿瘤发生高度相关的转录因子AP-2α(TFAP2A)是UM中最重要的调节因子。TFAP2A占据了UM中与癌基因溶质载体家族7成员8(SLC7A8)相关的预测超级增强子,从而阐明了一种调节癌基因表达的机制。总体而言,我们的数据说明了在UM中对超级增强子介导的癌基因依赖性进行表观遗传靶向的潜力,突出了一种可用于精准治疗的表观遗传脆弱性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa6c/12185695/6981abd08f6c/42003_2025_8338_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa6c/12185695/c09fba313945/42003_2025_8338_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa6c/12185695/680865d01134/42003_2025_8338_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa6c/12185695/34621d44422d/42003_2025_8338_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa6c/12185695/6e9986d0dbf9/42003_2025_8338_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa6c/12185695/40413e2d032e/42003_2025_8338_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa6c/12185695/2ebcb6c264fe/42003_2025_8338_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa6c/12185695/6981abd08f6c/42003_2025_8338_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa6c/12185695/c09fba313945/42003_2025_8338_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa6c/12185695/680865d01134/42003_2025_8338_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa6c/12185695/34621d44422d/42003_2025_8338_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa6c/12185695/6e9986d0dbf9/42003_2025_8338_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa6c/12185695/40413e2d032e/42003_2025_8338_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa6c/12185695/2ebcb6c264fe/42003_2025_8338_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/aa6c/12185695/6981abd08f6c/42003_2025_8338_Fig7_HTML.jpg

相似文献

1
Super-enhancers orchestrate transcriptional dysregulation and metabolic reprogramming in uveal melanoma.超级增强子在葡萄膜黑色素瘤中协调转录失调和代谢重编程。
Commun Biol. 2025 Jun 23;8(1):951. doi: 10.1038/s42003-025-08338-8.
2
Construction of an immune-related prognostic model and functional analysis of CEBPB in uveal melanoma: A STROBE-compliant observational study.葡萄膜黑色素瘤中免疫相关预后模型的构建及CEBPB的功能分析:一项符合STROBE标准的观察性研究。
Medicine (Baltimore). 2025 Jun 20;104(25):e42574. doi: 10.1097/MD.0000000000042574.
3
Prognostic significance of pigmentation and stem cell markers in Indian population of uveal melanoma.色素沉着和干细胞标志物在印度葡萄膜黑色素瘤患者中的预后意义
Br J Ophthalmol. 2025 Apr 21. doi: 10.1136/bjo-2024-325886.
4
Functional characterization of transcriptional enhancers in an Anopheles genetic locus controlling natural resistance to the malaria parasite, Plasmodium falciparum.在按蚊一个控制对恶性疟原虫天然抗性的基因位点中,转录增强子的功能特性研究
Epigenetics Chromatin. 2025 Jun 24;18(1):37. doi: 10.1186/s13072-025-00597-3.
5
Local tumor control and treatment related toxicity after plaque brachytherapy for uveal melanoma: A systematic review and a data pooled analysis.眼葡萄膜黑色素瘤瘤床近距离放疗后局部肿瘤控制和治疗相关毒性:系统评价和数据合并分析。
Radiother Oncol. 2022 Jan;166:15-25. doi: 10.1016/j.radonc.2021.11.007. Epub 2021 Nov 11.
6
Systemic treatments for metastatic cutaneous melanoma.转移性皮肤黑色素瘤的全身治疗
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
7
A Brief Overview of Uveal Melanoma Treatment Methods with a Focus on the Latest Advances.以最新进展为重点的葡萄膜黑色素瘤治疗方法概述
J Clin Med. 2025 Jun 8;14(12):4058. doi: 10.3390/jcm14124058.
8
Comprehensive single-cell chromatin and transcriptomic profiling of peripheral immune cells in nonsegmental vitiligo.非节段性白癜风外周免疫细胞的单细胞染色质和转录组综合分析
Br J Dermatol. 2025 Jun 20;193(1):115-124. doi: 10.1093/bjd/ljaf041.
9
Uveal Melanoma and the Lynch Syndrome Tumor Spectrum.葡萄膜黑色素瘤与林奇综合征肿瘤谱
JAMA Ophthalmol. 2025 Jun 18. doi: 10.1001/jamaophthalmol.2025.1779.
10
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.

本文引用的文献

1
Targeting FOXM1 condensates reduces breast tumour growth and metastasis.靶向FOXM1凝聚物可减少乳腺肿瘤的生长和转移。
Nature. 2025 Feb;638(8052):1112-1121. doi: 10.1038/s41586-024-08421-w. Epub 2025 Jan 15.
2
Facilitating integrative and personalized oncology omics analysis with UCSCXenaShiny.使用 UCSCXenaShiny 促进肿瘤组学分析的整合和个性化。
Commun Biol. 2024 Sep 28;7(1):1200. doi: 10.1038/s42003-024-06891-2.
3
TWEAK/Fn14 signalling driven super-enhancer reprogramming promotes pro-metastatic metabolic rewiring in triple-negative breast cancer.
TWEAK/Fn14 信号驱动的超级增强子重编程促进三阴性乳腺癌的促转移代谢重排。
Nat Commun. 2024 Jul 5;15(1):5638. doi: 10.1038/s41467-024-50071-z.
4
Effects of super-enhancers in cancer metastasis: mechanisms and therapeutic targets.超级增强子在癌症转移中的作用:机制和治疗靶点。
Mol Cancer. 2024 Jun 7;23(1):122. doi: 10.1186/s12943-024-02033-8.
5
Targeting Super-Enhancer-Driven Transcriptional Dependencies Suppresses Aberrant Hedgehog Pathway Activation and Overcomes Smoothened Inhibitor Resistance.靶向超级增强子驱动的转录依赖性抑制异常 Hedgehog 信号通路激活并克服 Smoothened 抑制剂耐药性。
Cancer Res. 2024 Aug 15;84(16):2690-2706. doi: 10.1158/0008-5472.CAN-23-3306.
6
Epigenetic drug library screening reveals targeting DOT1L abrogates NAD synthesis by reprogramming H3K79 methylation in uveal melanoma.表观遗传药物文库筛选显示,靶向DOT1L可通过重编程葡萄膜黑色素瘤中的H3K79甲基化来消除NAD合成。
J Pharm Anal. 2023 Jan;13(1):24-38. doi: 10.1016/j.jpha.2022.11.008. Epub 2022 Nov 28.
7
Advances in the clinical management of uveal melanoma.葡萄膜黑色素瘤的临床治疗进展。
Nat Rev Clin Oncol. 2023 Feb;20(2):99-115. doi: 10.1038/s41571-022-00714-1. Epub 2023 Jan 4.
8
Dynamic partitioning of branched-chain amino acids-derived nitrogen supports renal cancer progression.支链氨基酸衍生氮的动态分区支持肾癌进展。
Nat Commun. 2022 Dec 20;13(1):7830. doi: 10.1038/s41467-022-35036-4.
9
Reciprocal positive regulation between BRD4 and YAP in GNAQ-mutant uveal melanoma cells confers sensitivity to BET inhibitors.BRD4 和 YAP 在 GNAQ 突变性葡萄膜黑素瘤细胞中的相互正调控赋予 BET 抑制剂敏感性。
Pharmacol Res. 2022 Oct;184:106464. doi: 10.1016/j.phrs.2022.106464. Epub 2022 Sep 24.
10
Super-enhancer hypermutation alters oncogene expression in B cell lymphoma.超级增强子突变改变了 B 细胞淋巴瘤中的癌基因表达。
Nature. 2022 Jul;607(7920):808-815. doi: 10.1038/s41586-022-04906-8. Epub 2022 Jul 6.